Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series

2018 ◽  
Vol 42 (4) ◽  
pp. 821-825 ◽  
Author(s):  
Andrew Ukleja ◽  
Chau To ◽  
Alicia Alvarez ◽  
Luis F. Lara
Keyword(s):  
Short Bowel Syndrome ◽  
Case Series ◽  
Term Therapy ◽  
Short Bowel ◽  
Parenteral Support ◽  
Long Term Therapy

scholarly journals Imaging in phenytoin induced neurotoxicity: a case series

2017 ◽  
Vol 6 (1) ◽  
pp. 355
Author(s):  
Manali Arora ◽  
Deb Kumar Boruah ◽  
Vishal Thakker ◽  
Sangeeta Bhanwra
Keyword(s):  
Side Effects ◽  
Megaloblastic Anemia ◽  
Cerebellar Atrophy ◽  
Case Series ◽  
Cerebral Atrophy ◽  
Term Therapy ◽  
Seizure Disorders ◽  
Anti Epileptic Drug ◽  
Long Term Therapy

Phenytoin is a commonly used anti-epileptic drug for various types of seizure disorders except for absent seizures. Long term dose dependant neurological side effects of phenytoin therapy include cerebellar atrophy, cerebral atrophy and brain stem atrophy. Skull hyperostosis, gum hypertrophy and megaloblastic anemia are other known effects of Long term therapy. We present four cases depicting clinical and neuroimaging findings of Phenytoin induced Toxicity.

119. Intravenous immunoglobulins (IVIG) as long-term therapy in general myasthenia gravis – A case series

2009 ◽  
Vol 120 (1) ◽  
pp. e50-e51
Author(s):  
A. Wellek ◽  
C. Eienbröker ◽  
B. von Hagen ◽  
W.H. Oertel ◽  
N. Sommer ◽  
...  
Keyword(s):  
Myasthenia Gravis ◽  
Case Series ◽  
Intravenous Immunoglobulins ◽  
Term Therapy ◽  
Long Term Therapy

Intravenous immunoglobulins (IVIG) as long-term therapy in general myasthenia gravis: A case series

2008 ◽  
Vol 39 (01) ◽  
Author(s):  
A Wellek ◽  
C Eienbröker ◽  
B von Hagen ◽  
WH Oertel ◽  
N Sommer ◽  
...  
Keyword(s):  
Myasthenia Gravis ◽  
Case Series ◽  
Intravenous Immunoglobulins ◽  
Term Therapy ◽  
Long Term Therapy

Antithrombotic Therapy for DVT/PE

1997 ◽  
Vol 17 (03) ◽  
pp. 161-162
Author(s):  
Thomas Hyers
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Oral Anticoagulants ◽  
Cost Effective ◽  
Therapeutic Agents ◽  
Great Promise ◽  
Term Therapy ◽  
Low Molecular Weight ◽  
Long Term Therapy

SummaryProblems with unfractionated heparin as an antithrombotic have led to the development of new therapeutic agents. Of these, low molecular weight heparin shows great promise and has led to out-patient therapy of DVT/PE in selected patients. Oral anticoagulants remain the choice for long-term therapy. More cost-effective ways to give oral anticoagulants are needed.

Office-based post-marketing surveillance study on the influence of long term therapy with aripiprazole in patients with schizophrenia

2007 ◽  
Vol 40 (05) ◽  
Author(s):  
M Kungel ◽  
A Engelhardt ◽  
T Spevakné-Göröcs ◽  
M Ebrecht ◽  
C Werner ◽  
...  
Keyword(s):  
Surveillance Study ◽  
Term Therapy ◽  
Post Marketing Surveillance ◽  
Post Marketing ◽  
Long Term Therapy
Sign in / Sign up

Export Citation Format

Share Document